Sanofi Gets Approval For Interlocutory Appeal In Taxotere MDL
Pharmaceutical company Sanofi will get a chance to ask the Fifth Circuit to end multidistrict litigation claiming it failed to warn cancer patients about the risk of eye injuries caused by...To view the full article, register now.
Already a subscriber? Click here to view full article